The regulatory landscape for actively personalized cancer immunotherapies

Nat Biotechnol. 2013 Oct;31(10):880-2. doi: 10.1038/nbt.2708.
No abstract available

Publication types

  • Letter

MeSH terms

  • Biomarkers, Tumor / metabolism
  • Cancer Vaccines / immunology
  • Humans
  • Immunotherapy / legislation & jurisprudence*
  • Neoplasms / immunology*
  • Neoplasms / prevention & control
  • Neoplasms / therapy*
  • Precision Medicine*
  • Social Control, Formal*

Substances

  • Biomarkers, Tumor
  • Cancer Vaccines